One intriguing report published in 2020 found that GATA3 could increase the risks for HNSCC by stabilizing HIF-1 and, recently, another group reported that UBE2C is closely bound up with the poor outcome of HNSCC [5, 6]. This evidence concerns the gene GATA3 and head and neck squamous cell carcinoma.